Wednesday, July 01, 2015 10:48:15 AM
Through its unique approach to product development, Mel-Mont Medical has developed a one-of-a-kind medical device kit that empowers women to test for cervical cancer. Unlike traditional screening using Pap smear, woman can now use XytoTest™ in a private setting to avoid the embarrassment, anxiety, or fear caused by the regular cytology. The key drivers of the Company's product development approach include: Private setting; No qualified personnel required; FDA approved DNA technology; 94% sensitivity reducing false negatives; Higher population coverage; and Cost-effectiveness. XytoTest™ is a self-sampling kit of cervical specimens for the analysis of DNA for the 14 high-risk strains of Human Papilloma Virus (HPV). Mel-Mont currently operates in the USA and emerging countries including in Latin and South America with a focus in Colombia, where the company has offices, and Mexico.
GVDI
Any post by budfoxhub is not a recommendation to buy, hold or sell a security.
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • BLO • Apr 25, 2024 8:52 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM